Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

Capra raises funds for novel bioreactor

by Michael McCoy
June 11, 2022 | A version of this story appeared in Volume 100, Issue 21

 

Two people pose by a bioreactor.
Credit: Capra Biosciences
Capra Biosciences cofounders Elizabeth Onderko and Andrew Magyar pose with their bioreactor.

Capra Biosciences has raised $1.8 million in preseed funding to develop a continuous-flow bioreactor that it says will change the economics of making biobased chemicals. Capra plans to use the money to build a production-scale reactor at its facility in Manassas, Virginia. Its first product is the cosmetic ingredient retinol, the company says, and it intends to move into biobased lubricants. Capra’s cofounder and CEO, the biochemist Elizabeth Onderko, invented the bioreactor technology as a postdoctoral associate at the US Naval Research Laboratory.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.